Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MANH vs VEEV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MANH
Manhattan Associates, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$8.16B
5Y Perf.+55.9%
VEEV
Veeva Systems Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$27.20B
5Y Perf.-23.6%

MANH vs VEEV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MANH logoMANH
VEEV logoVEEV
IndustrySoftware - ApplicationMedical - Healthcare Information Services
Market Cap$8.16B$27.20B
Revenue (TTM)$1.10B$3.20B
Net Income (TTM)$217M$909M
Gross Margin55.6%75.5%
Operating Margin25.6%28.7%
Forward P/E25.7x18.9x
Total Debt$112M$96M
Cash & Equiv.$329M$1.42B

MANH vs VEEVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MANH
VEEV
StockMay 20May 26Return
Manhattan Associate… (MANH)100155.9+55.9%
Veeva Systems Inc. (VEEV)10076.4-23.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: MANH vs VEEV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VEEV leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Manhattan Associates, Inc. is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MANH
Manhattan Associates, Inc.
The Momentum Pick

MANH is the clearest fit if your priority is momentum and efficiency.

  • -24.6% vs VEEV's -28.1%
  • 28.0% ROA vs VEEV's 11.1%, ROIC 236.8% vs 12.9%
Best for: momentum and efficiency
VEEV
Veeva Systems Inc.
The Income Pick

VEEV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.77
  • Rev growth 16.3%, EPS growth 25.9%, 3Y rev CAGR 14.0%
  • 5.2% 10Y total return vs MANH's 135.2%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthVEEV logoVEEV16.3% revenue growth vs MANH's 3.7%
ValueVEEV logoVEEVLower P/E (18.9x vs 25.7x), PEG 1.04 vs 1.20
Quality / MarginsVEEV logoVEEV28.4% margin vs MANH's 19.7%
Stability / SafetyVEEV logoVEEVBeta 0.77 vs MANH's 1.10, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)MANH logoMANH-24.6% vs VEEV's -28.1%
Efficiency (ROA)MANH logoMANH28.0% ROA vs VEEV's 11.1%, ROIC 236.8% vs 12.9%

MANH vs VEEV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MANHManhattan Associates, Inc.
FY 2025
Service, Other
46.5%$503M
Cloud Subscriptions
37.7%$408M
Maintenance
12.0%$130M
Hardware
2.4%$25M
License and Maintenance
1.4%$15M
VEEVVeeva Systems Inc.
FY 2025
Subscription Services Veeva Research And Development
43.0%$1.2B
Subscription Services Veeva Commercial Cloud
40.2%$1.1B
Professional Services Veeva Research And Development
10.1%$277M
Professional Services Veeva Commercial Cloud
6.7%$185M

MANH vs VEEV — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVEEVLAGGINGMANH

Income & Cash Flow (Last 12 Months)

VEEV leads this category, winning 6 of 6 comparable metrics.

VEEV is the larger business by revenue, generating $3.2B annually — 2.9x MANH's $1.1B. VEEV is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to MANH's 19.7%. On growth, VEEV holds the edge at +16.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
RevenueTrailing 12 months$1.1B$3.2B
EBITDAEarnings before interest/tax$288M$956M
Net IncomeAfter-tax profit$217M$909M
Free Cash FlowCash after capex$380M$1.4B
Gross MarginGross profit ÷ Revenue+55.6%+75.5%
Operating MarginEBIT ÷ Revenue+25.6%+28.7%
Net MarginNet income ÷ Revenue+19.7%+28.4%
FCF MarginFCF ÷ Revenue+34.5%+43.7%
Rev. Growth (YoY)Latest quarter vs prior year+7.4%+16.0%
EPS Growth (YoY)Latest quarter vs prior year-3.5%+23.9%
VEEV leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

VEEV leads this category, winning 5 of 7 comparable metrics.

At 30.8x trailing earnings, VEEV trades at a 20% valuation discount to MANH's 38.3x P/E. Adjusting for growth (PEG ratio), VEEV offers better value at 1.69x vs MANH's 1.78x — a lower PEG means you pay less per unit of expected earnings growth.

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
Market CapShares × price$8.2B$27.2B
Enterprise ValueMkt cap + debt − cash$7.9B$25.9B
Trailing P/EPrice ÷ TTM EPS38.28x30.75x
Forward P/EPrice ÷ next-FY EPS est.25.72x18.88x
PEG RatioP/E ÷ EPS growth rate1.78x1.69x
EV / EBITDAEnterprise value multiple27.49x28.23x
Price / SalesMarket cap ÷ Revenue7.55x8.51x
Price / BookPrice ÷ Book value/share26.73x3.87x
Price / FCFMarket cap ÷ FCF21.83x19.22x
VEEV leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

MANH leads this category, winning 4 of 7 comparable metrics.

MANH delivers a 78.2% return on equity — every $100 of shareholder capital generates $78 in annual profit, vs $13 for VEEV. VEEV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MANH's 0.36x.

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
ROE (TTM)Return on equity+78.2%+13.4%
ROA (TTM)Return on assets+28.0%+11.1%
ROICReturn on invested capital+2.4%+12.9%
ROCEReturn on capital employed+76.3%+13.8%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.36x0.01x
Net DebtTotal debt minus cash-$216M-$1.3B
Cash & Equiv.Liquid assets$329M$1.4B
Total DebtShort + long-term debt$112M$96M
Interest CoverageEBIT ÷ Interest expense
MANH leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — MANH and VEEV each lead in 3 of 6 comparable metrics.

A $10,000 investment in MANH five years ago would be worth $10,433 today (with dividends reinvested), compared to $6,478 for VEEV. Over the past 12 months, MANH leads with a -24.6% total return vs VEEV's -28.1%. The 3-year compound annual growth rate (CAGR) favors VEEV at -2.0% vs MANH's -6.7% — a key indicator of consistent wealth creation.

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
YTD ReturnYear-to-date-17.6%-23.8%
1-Year ReturnPast 12 months-24.6%-28.1%
3-Year ReturnCumulative with dividends-18.7%-5.8%
5-Year ReturnCumulative with dividends+4.3%-35.2%
10-Year ReturnCumulative with dividends+135.2%+519.6%
CAGR (3Y)Annualised 3-year return-6.7%-2.0%
Evenly matched — MANH and VEEV each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MANH and VEEV each lead in 1 of 2 comparable metrics.

VEEV is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than MANH's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
Beta (5Y)Sensitivity to S&P 5001.10x0.77x
52-Week HighHighest price in past year$247.22$310.50
52-Week LowLowest price in past year$119.06$148.05
% of 52W HighCurrent price vs 52-week peak+55.7%+53.9%
RSI (14)Momentum oscillator 0–10055.153.8
Avg Volume (50D)Average daily shares traded674K2.2M
Evenly matched — MANH and VEEV each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates MANH as "Buy" and VEEV as "Buy". Consensus price targets imply 67.4% upside for VEEV (target: $280) vs 43.1% for MANH (target: $197).

MetricMANH logoMANHManhattan Associa…VEEV logoVEEVVeeva Systems Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$197.25$280.10
# AnalystsCovering analysts1542
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.9%+0.6%
Insufficient data to determine a leader in this category.
Key Takeaway

VEEV leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). MANH leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallVeeva Systems Inc. (VEEV)Leads 2 of 6 categories
Loading custom metrics...

MANH vs VEEV: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MANH or VEEV a better buy right now?

For growth investors, Veeva Systems Inc.

(VEEV) is the stronger pick with 16. 3% revenue growth year-over-year, versus 3. 7% for Manhattan Associates, Inc. (MANH). Veeva Systems Inc. (VEEV) offers the better valuation at 30. 8x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Manhattan Associates, Inc. (MANH) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MANH or VEEV?

On trailing P/E, Veeva Systems Inc.

(VEEV) is the cheapest at 30. 8x versus Manhattan Associates, Inc. at 38. 3x. On forward P/E, Veeva Systems Inc. is actually cheaper at 18. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Veeva Systems Inc. wins at 1. 04x versus Manhattan Associates, Inc. 's 1. 20x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — MANH or VEEV?

Over the past 5 years, Manhattan Associates, Inc.

(MANH) delivered a total return of +4. 3%, compared to -35. 2% for Veeva Systems Inc. (VEEV). Over 10 years, the gap is even starker: VEEV returned +519. 6% versus MANH's +135. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MANH or VEEV?

By beta (market sensitivity over 5 years), Veeva Systems Inc.

(VEEV) is the lower-risk stock at 0. 77β versus Manhattan Associates, Inc. 's 1. 10β — meaning MANH is approximately 42% more volatile than VEEV relative to the S&P 500. On balance sheet safety, Veeva Systems Inc. (VEEV) carries a lower debt/equity ratio of 1% versus 36% for Manhattan Associates, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MANH or VEEV?

By revenue growth (latest reported year), Veeva Systems Inc.

(VEEV) is pulling ahead at 16. 3% versus 3. 7% for Manhattan Associates, Inc. (MANH). On earnings-per-share growth, the picture is similar: Veeva Systems Inc. grew EPS 25. 9% year-over-year, compared to 2. 6% for Manhattan Associates, Inc.. Over a 3-year CAGR, VEEV leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MANH or VEEV?

Veeva Systems Inc.

(VEEV) is the more profitable company, earning 28. 4% net margin versus 20. 3% for Manhattan Associates, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus 26. 1% for MANH. At the gross margin level — before operating expenses — VEEV leads at 75. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MANH or VEEV more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Veeva Systems Inc. (VEEV) is the more undervalued stock at a PEG of 1. 04x versus Manhattan Associates, Inc. 's 1. 20x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Veeva Systems Inc. (VEEV) trades at 18. 9x forward P/E versus 25. 7x for Manhattan Associates, Inc. — 6. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VEEV: 67. 4% to $280. 10.

08

Which pays a better dividend — MANH or VEEV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is MANH or VEEV better for a retirement portfolio?

For long-horizon retirement investors, Veeva Systems Inc.

(VEEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 77), +519. 6% 10Y return). Both have compounded well over 10 years (VEEV: +519. 6%, MANH: +135. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MANH and VEEV?

These companies operate in different sectors (MANH (Technology) and VEEV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MANH is a small-cap quality compounder stock; VEEV is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MANH

Steady Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 11%
Run This Screen
Stocks Like

VEEV

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MANH and VEEV on the metrics below

Revenue Growth>
%
(MANH: 7.4% · VEEV: 16.0%)
Net Margin>
%
(MANH: 19.7% · VEEV: 28.4%)
P/E Ratio<
x
(MANH: 38.3x · VEEV: 30.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.